Connect with us

Cannabis News

Canadian Cannabis Company Announces License to Sell Cocaine!

Published

on


Adastra Labs, a Langley-based company known for its cutting-edge cannabis and ethnobotanical products, has recently received approval from Health Canada for an amended license. This license permits the lawful possession, production, distribution, and sale of a highly regulated substance.

 

Following decriminalizing personal amounts of controlled substances in British Columbia, Adastra can now interact with up to 250 grams of cocaine and import coca leaves to create and synthesize the substance.

 

As a leading manufacturer and supplier of innovative scientific products, Adastra Labs is excited to continue exploring new avenues in ethnobotanicals and beyond.

 

Prime Minister Justin Trudeau and B.C. Premier David Eby was caught off guard by Health Canada’s sudden approval. Expressing his surprise, the premier said the announcement had astonished him. He added that this decision was not included in the provincial plan and that Health Canada did not engage with the B.C. government before making this move.

 

In response to the premier’s remarks, Adastra Labs released a statement on Friday retracting any suggestion of current activities involving cocaine under their Dealer’s License. The company emphasized that any future activities would only be carried out within the bounds of legal permission granted by the license and after consultation with relevant Provincial Governments.

 

It’s important to note that the dealer’s license obtained by Adastra does not allow the sale of coca leaf, psilocybin, or cocaine to the general public. Instead, the license is limited to authorized dealers such as pharmacists, practitioners, hospitals, or holders of section 56(1) exemption for research purposes under the Controlled Drugs and Substances Act (CDSA).

 

To combat the ongoing overdose crisis that resulted in the deaths of more than 11,000 British Columbians since 2016, the province has begun the process of decriminalizing up to 2.5 grams of drugs as of January 31st.

 

In Canada, controlled substance possession, production, or sale is generally illegal unless authorized for medical, scientific, or industrial purposes. Possession of cocaine can carry a sentence of up to seven years in prison, while production or trafficking can result in life imprisonment.

 

However, recent developments, such as the decriminalization efforts in British Columbia and Adastra Labs’ approval for lawful possession, production, and distribution of cocaine, indicate that discussions around drug regulation and harm reduction are evolving and progressing.

 

B.C. opposition leader says the move is ‘legalizing cocaine trafficking

In a recent statement, Adastra Labs confirmed that their amended license now permits them to “interact” with a maximum of 250 grams of cocaine and to import coca leaves to manufacture and synthesize the substance.

 

CEO Michael Forbes emphasized that Adastra is committed to staying at the forefront of drug regulations and exploring innovative solutions to promote harm reduction. Forbes stated that the company proactively pursued the amendment to its Dealer’s License to include cocaine in December 2022 and will evaluate how the commercialization of the substance fits into its business model to support the demand for a safe supply.

 

Overall, Adastra Labs is dedicated to exploring innovative solutions to drug regulation and harm reduction challenges while maintaining a solid commitment to safety and compliance.

 

Following Adastra Labs’ approval for lawful possession, production, and distribution of cocaine, Health Canada issued a statement reminding the company of the very narrow criterion of their license. The statement warns that if the strict requirements are not followed, Health Canada will not hesitate to take action, including revoking the license.

 

The announcement of Adastra’s license amendment has also sparked controversy, with Opposition leader Kevin Falcon criticizing the move during a question period at the B.C. Legislature. Falcon argues that cocaine is not prescribed and is not a safe substance and that commercializing it as a business opportunity amounts to legalizing cocaine trafficking.

 

This debate highlights the ongoing discussions around drug regulation and harm reduction in Canada. While some may view Adastra’s license amendment as a step towards providing a safer supply of cocaine, others see it as promoting the use of a harmful and illegal substance. The topic of drug regulation and harm reduction remains a complex and nuanced issue, with many differing opinions and viewpoints.

 

The B.C. Centre on Substance Use has expressed uncertainty regarding the exemption granted to Adastra Labs for the lawful possession, production, sale, and distribution of cocaine. Kevin Hollett, a spokesman for the agency, stated that they know “very little” about the exemption and that the safe supply policy released in July 2021 focuses primarily on opioids.

 

Hollett acknowledged that he is not clear on how the exemption for cocaine might fit into the safe supply policy, if at all. This highlights the need for further discussion and clarification around regulating and using controlled substances in Canada, particularly as the country faces an ongoing overdose crisis.

 

 

Conclusion

The issue of drug regulation and harm reduction is complex and multifaceted. As evidenced by the ongoing overdose crisis in British Columbia and other parts of the world, current drug policy and enforcement approaches fail to address the root causes of drug addiction and related harms.

 

Recent developments, such as the decriminalization efforts in British Columbia and the approval of Adastra Labs’ license amendment to include cocaine, indicate a shifting perspective toward drug regulation and harm reduction. While these developments have received criticism and scrutiny, they also provide an opportunity to explore new and innovative approaches to drug policy that prioritize harm reduction and public health.

 

Moving forward, policymakers, healthcare professionals, and communities must continue engaging in constructive dialogue and collaboration to develop evidence-based solutions prioritizing the health and well-being of individuals affected by drug addiction. By adopting a compassionate and evidence-based approach to drug policy and regulation, we can work towards creating safer and more equitable communities for everyone.

 

COCAINE REGULATIONS, READ ON…

COCAINE DERITIVITES DESHEDULED

The Curious Case of a Cocaine Derivative Called [18F] FP-CIT



Source link

Continue Reading

Cannabis News

The 3 Biggest Winners from Rescheduling Cannabis?

Published

on

By


tax money weed

President Joe Biden’s support of the administration’s decision to reschedule cannabis from Schedule I to Schedule III is likely to result in considerable financial benefits for large, legal cannabis businesses and the illicit market. This action may lessen the restrictions imposed by IRS tax regulation 280E, which has banned cannabis businesses from deducting standard business expenditures. Which cannabis firms will gain the most from this change?

 

The illicit market will get a huge boost by removing the punshiments associated with getting caught dealing or transporting a Schedule 1 drug.  Now that the fines, prison sentences, and desire to enforce Schedule 3 crimes is lessened, look for the illicit market to boom across America.  It is estimated that the illegal cannabis market is 3x the size of the legal US market as of 2024, so look for that multiple to expand if Schedule 3 is enacted.  Removing a negative incentive in economics always leads to predictable action.

 

In the legal market, the largest MSOS, or those that paid the most taxes, have the most to gain by a repeal of the 280E tax code and future tax credit or refunds coming their way

 

Industry Leaders in Tax Payments

 

Rescheduling cannabis will abolish the onerous 280E tax law, potentially freeing up more than a billion dollars in tax savings for the business. Curaleaf (OTC: CURLF) and Trulieve (OTC: TCNNF), both of which make considerable tax payments, are among the firms most likely to profit. Repealing 280E limits would allow these businesses to deduct typical business costs, greatly improving their financial situation.

Truelive alone stands to get $113,000,000 in tax refunds and savings!

Senior analyst Pablo Zuanic of Zuanic & Associates believes that these tax reductions may result in improved cash flows, allowing these businesses to reinvest in development and growth. In the quickly changing cannabis market, having this kind of financial flexibility is essential for keeping a competitive advantage and encouraging creativity.

 

Zuanic has consistently highlighted the disparity between current market valuations and the potential upside, particularly if federal legalization occurs. He emphasizes that immediate cash flow improvements could lead to substantial revaluation of these companies. By enabling the deduction of ordinary business expenses, the financial statements of these companies would more accurately reflect their true profitability, attracting more investors and boosting market confidence.

 

The potential tax savings are a temporary relief and a game-changer for the industry. Analysts believe that the improved cash flow could result in substantial revaluations of cannabis companies. For Curaleaf and Trulieve, this change would mean their financial statements would better represent their actual profitability, leading to increased investments and further expansion opportunities.

 

Curaleaf’s Financial Outlook

 

Beacon Securities’ Russell Stanley sheds light on Curaleaf’s financial landscape, highlighting the company’s adept management of operating cash flow. This proficiency facilitated a successful debt repurchase post-quarter, significantly enhancing its financial stability. With the anticipated rescheduling of cannabis and the potential enactment of the SAFER Banking Act, Curaleaf stands to benefit from a transformed financial environment, potentially witnessing a substantial surge in its operating cash flow by up to 92% and free cash flow by 188%.

 

Wedbush Securities recently released a report on Curaleaf, elevating the stock’s 12-month price target from $6.00 to $7.00 while maintaining a buy recommendation. The report underscores Curaleaf’s commendable performance in key domestic markets like Connecticut, Arizona, Maryland, and New York. Projections indicate a revenue uptick to $1.50 billion by 2025, coupled with improvements in overall profitability. This optimistic forecast reflects the company’s robust financial position and its strategic market presence.

 

Proactive debt management techniques and well-thought-out market positioning highlight Curaleaf’s potential for long-term development and financial success in the changing cannabis industry. Curaleaf is in a strong position to benefit from the rescheduling of banking and cannabis legislation, which may lower regulatory obstacles and further establish the company’s leadership in the cannabis market.

 

Unlocking Trulieve’s Growth Potential

 

Trulieve’s Growth Trajectory

 

Trulieve’s growth trajectory is drawing attention, particularly from Needham’s Matt McGinley, who emphasizes the company’s operational efficiency. McGinley points out that Trulieve has achieved its highest gross margin and EBITDA rates observed in over two years, indicating strong operational performance. This efficiency positions Trulieve favorably for capitalizing on emerging opportunities in the cannabis market.

 

Key legislative advancements in pivotal markets such as Florida and Pennsylvania present significant growth potential for Trulieve. As these markets potentially transition to adult-use cannabis, Trulieve stands to benefit from increased demand and expanded market reach. Leveraging its operational efficiency and established market presence, Trulieve is poised to capitalize on these legislative shifts to drive revenue growth and enhance shareholder value.

 

Trulieve is positioned to be a major participant in the growth of the cannabis sector due to its strategic focus on operational excellence and its flexibility in responding to changing regulatory environments. Trulieve is in an excellent position to maintain its growth trajectory and establish itself as a top cannabis supplier, thanks to encouraging legislative changes and a proven track record of high performance.

 

Analysts’ Industry Impact Assessment

 

Viridian Capital Advisors offers insights into the industry impact, noting that ten MSOs exceeded EBITDA estimates by $37 million in the first quarter of 2024. This performance suggests that initial projections may have been conservative, indicating a positive trend for cannabis companies. Analysts from Viridian specifically highlight Curaleaf and Trulieve, among others, as poised to benefit from the financial changes resulting from the removal of 280E tax restrictions.

 

The long-term outlook for the cannabis industry remains bullish, with potential federal legalization driving substantial valuation growth. Pablo Zuanic from Zuanic & Associates suggests that the US market alone could justify over $110 billion in valuations by 2030 assuming federal legalization. The removal of tax restrictions would directly impact bottom lines, potentially leading to significant valuation increases for many cannabis stocks.

 

All things considered, the possible repeal of the 280E tax laws offers cannabis businesses a big chance to improve their financial standing and market value. As analysts speculate that early projections may have overestimated the sector’s potential, businesses like Curaleaf and Trulieve might gain from more cash flow and better profitability, setting them up for long-term success in the changing cannabis market environment.

 

Bottom Line

 

The impending rescheduling of cannabis and the potential repeal of IRS tax regulation 280E offer a substantial opportunity for cannabis companies to strengthen their financial positions and market appeal. Industry leaders such as Curaleaf and Trulieve stand to benefit significantly, with projected increases in cash flow and profitability paving the way for sustained growth. Analysts anticipate a positive market response, with potential valuation growth and a bullish outlook for the long-term trajectory of the cannabis industry. These regulatory changes mark a pivotal moment, allowing businesses to capitalize on newfound financial flexibility and attract investor confidence. As the sector continues to evolve, Curaleaf, Trulieve, and other key players are positioned to thrive, driving innovation and shaping the future of the cannabis market.

 

WINNERS AND LOSERS FROM SCHEDULE 3, READ ON…

WINNERS FROM SCHEDULE 3 MARIJUANA

WINNERS AND LOSERS FROM SCHEDULE 3 CANNABIS, BET ON THIS!



Source link

Continue Reading

Cannabis News

Is Your Kid Smoking or Vaping Weed?

Published

on

By


is my kid smoking weed

Marijuana for recreational and medicinal purposes is becoming more widely available and simpler to purchase every day. Furthermore, opinions about the drug’s possible risks have changed as a result of recent legislative modifications, especially among young teenagers.

 

While proper use of marijuana can offer health benefits for specific conditions, inappropriate use can lead to a variety of problems. It can severely impact health, situational judgment, memory, coordination, and more.

 

Given that marijuana has rapidly become a much more commonly used drug among young people, it is crucial to recognize the main signs of marijuana use in teens to ensure their safety and well-being.

 

Statistics on Child Marijuana Use

 

Though the stats may surprise you, marijuana is the most often used narcotic among teenagers. Among children between the ages of 12 and 17, the National Center for Drug Abuse reports that:

 

– Nearly 44% have tried marijuana in their lifetime, up from 37% in 2019.

– 35% used marijuana in the past year.

– Almost 7% of 12th graders use marijuana daily.

 

Regretfully, eighth, ninth, and tenth kids are exposed to an alarmingly high level of marijuana. Early usage is problematic since those who start using earlier have a greater likelihood of heavier use later in life.

 

How THC Impacts the Brain

 

The active element in cannabis is tetrahydrocannabinol (THC), which produces the “high” associated with marijuana. THC can be ingested by smoking cannabis flowers, vaping concentrated forms, or eating THC-infused foods. THC impacts the brain by interfering with processes that are typically controlled by naturally existing endocannabinoids.

 

The brain grows from birth to the mid-twenties, and consuming marijuana at a young age can interrupt this important development. Early marijuana usage appears to influence brain development, according to recent research.

 

The effects of cannabis on the brain are extensive:

 

– Executive Functioning: Skills necessary for daily life, such as focus, memory, problem-solving, planning, reasoning, and emotional control, are compromised.

– Working Memory: The ability to remember and later recall or use information is reduced.

– Lingering Effects: The impact of cannabis use can last well beyond the period of intoxication. Even if someone smokes on a weekend, the effects can persist into the following week. Regular use leads to a persistent decline in executive functioning, working memory, and other cognitive areas.

 

Cannabis use interferes with the brain’s circuits, and it remains uncertain whether the brain can fully recover if marijuana use is discontinued.

 

Signs Your Child is Using Cannabis

 

Recognizing if your child is using marijuana can involve noticing various signs, including:

 

– Hair or clothes with a pungent marijuana smell

– Red or bloodshot eyes

– Delayed reaction times

– Mood swings

– Laziness and tiredness

– Presence of marijuana-related paraphernalia

– Paranoia or anxiousness

– Increased hunger or “munchies”

 

Visible Signs of Marijuana Use

 

Shortly after usage, marijuana’s effects can be perceived both visually and aromatically. It is very suggestive of marijuana usage if your adolescent returns home with red or bloodshot eyes. Physical and mental delays in response times and problems with muscular coordination are further symptoms.

 

Cannabis has a unique fragrance that is another warning clue; it is frequently characterized as having a pungent, musky smell like that of a skunk. On your teen’s clothes, this odor might cling rather readily.

 

Changes in Emotional State

 

The body and mind might react differently to different strains or varieties of marijuana. Teenage marijuana usage is frequently indicated by mood swings, lethargy, and general exhaustion in their day-to-day demeanor. Depending on how their body responds, they might also seem nervous and exhibit an elevated heart rate.

 

Your youngster may struggle to focus at job, school, or home as a result of these changes, which frequently results in subpar performance and grades. This decrease might be a clear indication that marijuana use has turned into an addiction.

 

Educating Your Child about Marijuana

 

Regardless of whether you suspect your child is using cannabis, it’s important to discuss it. Parents and caregivers should talk about all types of dangerous substances, including nicotine, alcohol, and cannabis, with children as early as elementary school.

 

It’s important to be proactive and talk to your youngster about the risks associated with marijuana. These talks may serve to deter marijuana usage or at the very least postpone the initial experience until the mid-20s, when the brain is more completely matured.

 

As teenagers become older, their need for independence grows, which makes it harder for parents to control their actions. Still, parents need to persevere. It is significantly more dangerous to consume cannabis than it is uncomfortable to have a difficult talk.

 

Addressing Marijuana Use and Seeking Help

 

For teenagers’ wellbeing, it is essential to identify and treat marijuana usage. It’s crucial to handle the matter with compassion and support if you think your child may be consuming marijuana. Discussing its usage, the rationale behind it, and any possible hazards should come first in an honest and nonjudgmental discussion. Give your child access to a secure environment where they may talk about their thoughts and experiences. You can gain insight into their viewpoint and advice on how to make better decisions by having this discussion.

 

If using marijuana has become troublesome, you might think about getting professional assistance. Resources like therapists, counselors, and specialty treatment programs can provide your kid with the help they need. These specialists are qualified to deal with underlying problems including stress, peer pressure, or mental health disorders that may be causing drug use. Early intervention can stop the usage from getting worse and support your kid in creating healthy coping mechanisms. Getting a medical expert involved can also offer a methodical way to handle the matter and guarantee that your adolescent gets the treatment they need.

 

It is critical to be involved and supportive throughout the process. Encourage your kid to participate in activities that support their well-being and offer positive reinforcement for good habits. Stay educated about the services available in your area, and consider joining support groups for parents struggling with similar challenges. You can assist your child in navigating this difficult period and promote a healthy, drug-free future by keeping open communication and obtaining expert support as required.

 

Bottom Line

 

Parents need to be vigilant about the signs of marijuana use in their children, given its prevalence among teenagers and its potential impact on their health and development. Early detection, open communication, and seeking professional help if needed are key strategies for addressing marijuana use in adolescents. By providing support, education, and access to resources, parents can help guide their children towards healthier choices and a drug-free future.

 

HOW TO HAVE “THE TALK” WITH YOUR KIDS, READ ON..

TALKING TO YOUR KID ABOUT MARIJUANA TALK

TALKING TO YOUR KIDS ABOUT WEED, AGE APPRORIATE TIPS!



Source link

Continue Reading

Cannabis News

How Did Hidden Leaf Cannabis Become the Leader of the Ontario Marijuana Market?

Published

on

By


Hidden Leaf cannabis store

Cannabis.net sat down with Ontario’s hottest cannabis store to find out some of their “secret sauce” that made them the best dispensary in Ontario, Canada.

Q: How did you come up with the name Hidden Leaf for Ontario’s premier cannabis dispensaries?

A: Growing up, I was always a big fan of the anime show Naruto, where the main character grew up in a village called “Hidden Leaf Village.” Naruto’s backstory really resonated with me, inspiring me to name the company Hidden Leaf. As Ontario’s premier Burlington and Scarborough Dispensary, we strive to embody the spirit of community and resilience found in Naruto’s tale.

Q: What makes Hidden Leaf the best dispensary in Scarborough or Burlington?

A: At Hidden Leaf, customer service sets us apart. Unlike many other dispensaries that curate their menu based on profitability, our customers drive our selection. We actively encourage our patrons from both our cannabis store Scarborough and cannabis store Burlington to send in their product recommendations, which we try our best to stock. Plus, we offer the most competitive pricing, making cannabis affordable for everyone. Our commitment to these principles makes us stand out in the Scarborough dispensary and Burlington dispensary markets.

Q: How did you first get into the Canadian cannabis market? What made you take the leap of faith?

A: From a young age, I’ve always wanted to own a business and had a passion for the cannabis industry, learning to grow plants and understanding the different types of concentrates. Taking the risk to enter the business felt right as it was a great way to expand my knowledge and participate actively in the burgeoning cannabis market in cities like Scarborough and Burlington.

Q: Canada was the first G7 country to legalize weed, what advice would you look back and give your past self? What do you wish you knew then that you know now?

A: Looking back, I wish I had learned more about the cannabis business earlier and entered the industry as soon as it was legalized. Now, understanding the different avenues to enter the cannabis industry, I would definitely consider owning my own grow facility among other ventures. This knowledge would have been invaluable from the start, especially in dynamic markets like those of our Cannabis Store Burlington and other locations.

Q: What are Hidden Leaf’s best strains, or what do customers come back for over and over?

A: Hidden Leaf carries a wide variety of brands and strains to cater to every customer’s needs. From budget-friendly options for those looking to save a few bucks to premium quality strains for the real cannabis connoisseurs, our selection is vast. Customers frequently return for our consistent quality and the breadth of our offerings, including popular cannabis flowers at both our Scarborough and Burlington locations.

Q: What has been the biggest challenges in setting up a cannabis business in Canada?

A: The biggest challenge has been finding the right location. Despite legalization, there’s still a stigma around cannabis with many landlords, making it hard to lease properties for cannabis businesses. Additionally, the market is quite saturated with many retailers opening up, so it’s crucial to choose strategic locations for our dispensaries to avoid excessive competition, particularly in areas served by our Scarborough dispensary and cannabis store Burlington.

Q: What do you think about the future of cannabis beverages?

A: The future of cannabis beverages and edibles is very promising. Many people who are new to cannabis are not fans of smoking, so THC beverages and edibles offer a fantastic alternative. These products are expected to attract a new wave of consumers looking to explore cannabis in a more familiar and accessible form.

Q: What is the best way for people to find out more about us or visit us? Website? Social media?

A: The best way for customers to find out more about Hidden Leaf is through our website. It’s the go-to place to find the closest location, whether that’s our Scarborough dispensary or cannabis store Burlington, and to explore our menu and pricing. Our website is a comprehensive resource for anyone interested in our products and services.

Q: If someone is trying to decide which dispensary to go to in Ontario, why should they go to Hidden Leaf?

A: At Hidden Leaf, it’s all about customer service and pricing. We don’t believe in upselling; instead, our goal is to find the best product within your budget. Our customers help shape our menus with their recommendations, which we order in every week. With very competitive pricing, we believe cannabis should be affordable for everyone, making our Burlington and Scarborough Dispensary the go-to choice for quality cannabis products and genuine customer care.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media